140
Views
16
CrossRef citations to date
0
Altmetric
Articles

Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation

, &
Pages 559-566 | Received 24 Apr 2017, Accepted 01 May 2018, Published online: 23 May 2018

References

  • Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320–332.
  • Uitto J, Has C, Bruckner-Tuderman L. Cell-based therapies for epidermolysis bullosa – from bench to bedside. J Dtsch Dermatol Ges. 2012;10:803–807.
  • Harries MJ, Meyer K, Chaudhry I, et al. Lichen planopilaris is characterized by immune privilege collapse of the hair follicle’s epithelial stem cell niche. J Pathol. 2013;231:236–247.
  • Petrova A, Ilic D, McGrath JA. Stem cell therapies for recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2010;163:1149–1156.
  • Petrof G, Abdul-Wahab A, McGrath JA. Cell therapy in dermatology. Cold Spring Harb Perspect Med. 2014;4:a015156.
  • Wagner JE, Ishida-Yamamoto A, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363:629–639.
  • Conget P, Rodriguez F, Kramer S, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429–431.
  • Abdul-Wahab A, Petrof G, McGrath JA. Bone marrow transplantation in epidermolysis bullosa. Immunotherapy. 2012;4:1859–1867.
  • Zhou H, Guo M, Bian C, et al. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. Biol Blood Marrow Transplant. 2010;16:403–412.
  • Herrmann R, Sturm M, Shaw K, et al. Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study. Int J Hematol. 2012;95:182–188.
  • Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69:1423–1429.
  • Scuderi N, Ceccarelli S, Onesti MG, et al. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant. 2013;22:779–795.
  • Sui W, Hou X, Che W, et al. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus. Clin Immunol. 2013;148:186–197.
  • Wang D, Zhang H, Cao M, et al. Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Ann Rheum Dis. 2011;70:1285–1288.
  • Cintolo JA, Datta J, Xu S, et al. Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma. Melanoma Res. 2016;26:1–11.
  • Lopez MN, Pereda C, Segal G, et al. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. J Clin Oncol. 2009;27:945–952.
  • Nilforoushzadeh M, Rahimi Jameh E, Jaffary F, et al. Hair follicle generation by injections of adult human follicular epithelial and dermal papilla cells into nude mice. Cell J. 2017;19:259–268.
  • Bachy V, Hervouet C, Becker PD, et al. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci U S A. 2013;110:3041–3046.
  • Kommareddy S, Baudner BC, Oh S, et al. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci. 2011;101:1021–1027.
  • Li G, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm. 2009;368:109–115.
  • Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol. 2005;14:719–726.
  • Yu J, Kalaria DR, Kalia YN. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. J Control Release. 2011;156:53–59. Dermatol. 2005;14:719–726.
  • Terhorst D, Fossum E, Baranska A, et al. Laser-assisted intradermal delivery of adjuvant-free vaccines targeting XCR1+ dendritic cells induces potent antitumoral responses. J Immunol. 2015;194:5895–5902.
  • Weiss R, Hessenberger M, Kitzmuller S, et al. Transcutaneous vaccination via laser microporation. J Control Release. 2012;162:391–399.
  • Bachhav YG, Summer S, Heinrich A, et al. Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release. 2010;146:31–36.
  • Haedersdal M, Erlendsson AM, Paasch U, et al. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol. 2016;74(5):981–1004.
  • Diameter of HEK-293 cell. Available from, Accessed on 21 March 2013. http://bionumbers.hms.harvard.edu/bionumber.aspx?id=108893
  • Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol. 1992;44:640–645.
  • Sekkat N, Kalia YN, Guy RH. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci. 2002;91:2376–2381.
  • Jacobi U, Kaiser M, Toll R, et al. Porcine ear skin: an in vitro model for human skin. Skin Res Technol. 2007;13:19–24.
  • Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm. 2001;215:51–56.
  • Bachhav YG, Heinrich A, Kalia YN. Using laser microporation to improve transdermal delivery of diclofenac: increasing bioavailability and the range of therapeutic applications. Eur J Pharm Biopharm. 2011;78:408–414.
  • Bachhav YG, Heinrich A, Kalia YN. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium: YAG fractional laser ablation technology. Eur J Pharm Biopharm. 2013;84:355–364.
  • Donnelly RF, Singh TR, Tunney MM, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res. 2009;26:2513–2522.
  • Freshney R. Culture of animal cells: a manual of basic technique. Alan R. Liss, Inc, New York; 1987. p. 117.
  • Kalia YN, Pirot F, Guy RH. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J. 1996;71:2692–2700.
  • Pirot F, Kalia YN, Stinchcomb AL, et al. Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A. 1997;94:1562–1567.
  • Moser K, Kriwet K, Froehlich C, et al. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm Res. 2001;18:1006–1011.
  • Dubey S, Kalia YN. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. J Control Release. 2010;145:203–209.
  • Halter M, Tona A, Bhadriraju K, et al. Automated live cell imaging of green fluorescent protein degradation in individual fibroblasts. Cytometry A. 2007;71:827–834.
  • Li X, Zhao X, Fang Y, et al. Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem. 1998;273:34970–34975.
  • Singhal M, Del Rio-Sancho S, Sonaje K, et al. Fractional laser ablation for the cutaneous delivery of triamcinolone acetonide from cryomilled polymeric microparticles: creating intraepidermal drug depots. Mol Pharm. 2016;13:500–511.
  • Yu J, Bachhav YG, Summer S, et al. Using controlled laser-microporation to increase transdermal delivery of prednisone. J Control Release. 2010;148:e71–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.